ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Taxol Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-35W17004
Home | Market Reports | Health| Health Conditions| Cancer
Global Taxol Market Research Report 2024
BUY CHAPTERS

Global Taxol Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-35W17004
Report
November 2025
Pages:159
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius Kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology

Taxol Market

The global Taxol market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Taxol is a chemotherapy medication primarily used to treat various types of cancer. Its active ingredient is paclitaxel, which is derived from the bark of the Pacific yew tree (Taxus brevifolia) or, more commonly, synthesized in the laboratory. Taxol works by interfering with the growth and division of cancer cells. Specifically, it binds to tubulin, a protein involved in cell division, and stabilizes microtubules, preventing them from breaking down. This disruption in microtubule dynamics ultimately leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells. Taxol is used to treat a variety of cancers, including breast cancer, ovarian cancer, lung cancer, and Kaposi's sarcoma. It is typically administered intravenously by a healthcare professional in a clinical setting. While Taxol can be effective in treating cancer, it may also cause side effects, including hair loss, nausea, vomiting, diarrhea, neuropathy (nerve damage), and bone marrow suppression. The severity and type of side effects experienced can vary from person to person.
From a downstream perspective, Ovarian Cancer accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Taxol leading manufacturers including Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, etc., dominate supply; the top five capture approximately % of global revenue, with Phyton leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Taxol market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Taxol Market Report

Report Metric Details
Report Name Taxol Market
Segment by Type
  • Natural Paclitaxel API
  • Semi-synthetic Paclitaxel API
Segment by Application
  • Ovarian Cancer
  • Cervical Cancer
  • Breast Cancer
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Taxol study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Taxol Market report?

Ans: The main players in the Taxol Market are Phyton, ScinoPharm, Novasep, Samyang, Polymed, TAPI (Teva), Fresenius-kabi, Huiang biopharma, Southpharma, Yunnan Hande, Hainan Yew Pharm, Jiangsu Yew Biotechnology

What are the Application segmentation covered in the Taxol Market report?

Ans: The Applications covered in the Taxol Market report are Ovarian Cancer, Cervical Cancer, Breast Cancer, Others

What are the Type segmentation covered in the Taxol Market report?

Ans: The Types covered in the Taxol Market report are Natural Paclitaxel API, Semi-synthetic Paclitaxel API

1 Study Coverage
1.1 Introduction to Taxol: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Taxol Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Natural Paclitaxel API
1.2.3 Semi-synthetic Paclitaxel API
1.3 Market Segmentation by Application
1.3.1 Global Taxol Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Ovarian Cancer
1.3.3 Cervical Cancer
1.3.4 Breast Cancer
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Taxol Revenue Estimates and Forecasts 2020-2031
2.2 Global Taxol Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Taxol Sales Estimates and Forecasts 2020-2031
2.4 Global Taxol Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Taxol Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Taxol Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Natural Paclitaxel API Market Size by Manufacturers
3.5.2 Semi-synthetic Paclitaxel API Market Size by Manufacturers
3.6 Global Taxol Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Taxol Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Taxol Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Taxol Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Taxol Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Taxol Sales and Revenue by Type (2020-2031)
6.4 North America Taxol Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Taxol Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Taxol Sales and Revenue by Type (2020-2031)
7.4 Europe Taxol Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Taxol Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Taxol Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Taxol Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Taxol Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Taxol Sales and Revenue by Type (2020-2031)
9.4 Central and South America Taxol Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Taxol Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Taxol Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Taxol Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Taxol Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Phyton
11.1.1 Phyton Corporation Information
11.1.2 Phyton Business Overview
11.1.3 Phyton Taxol Product Models, Descriptions and Specifications
11.1.4 Phyton Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Phyton Taxol Sales by Product in 2024
11.1.6 Phyton Taxol Sales by Application in 2024
11.1.7 Phyton Taxol Sales by Geographic Area in 2024
11.1.8 Phyton Taxol SWOT Analysis
11.1.9 Phyton Recent Developments
11.2 ScinoPharm
11.2.1 ScinoPharm Corporation Information
11.2.2 ScinoPharm Business Overview
11.2.3 ScinoPharm Taxol Product Models, Descriptions and Specifications
11.2.4 ScinoPharm Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 ScinoPharm Taxol Sales by Product in 2024
11.2.6 ScinoPharm Taxol Sales by Application in 2024
11.2.7 ScinoPharm Taxol Sales by Geographic Area in 2024
11.2.8 ScinoPharm Taxol SWOT Analysis
11.2.9 ScinoPharm Recent Developments
11.3 Novasep
11.3.1 Novasep Corporation Information
11.3.2 Novasep Business Overview
11.3.3 Novasep Taxol Product Models, Descriptions and Specifications
11.3.4 Novasep Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Novasep Taxol Sales by Product in 2024
11.3.6 Novasep Taxol Sales by Application in 2024
11.3.7 Novasep Taxol Sales by Geographic Area in 2024
11.3.8 Novasep Taxol SWOT Analysis
11.3.9 Novasep Recent Developments
11.4 Samyang
11.4.1 Samyang Corporation Information
11.4.2 Samyang Business Overview
11.4.3 Samyang Taxol Product Models, Descriptions and Specifications
11.4.4 Samyang Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Samyang Taxol Sales by Product in 2024
11.4.6 Samyang Taxol Sales by Application in 2024
11.4.7 Samyang Taxol Sales by Geographic Area in 2024
11.4.8 Samyang Taxol SWOT Analysis
11.4.9 Samyang Recent Developments
11.5 Polymed
11.5.1 Polymed Corporation Information
11.5.2 Polymed Business Overview
11.5.3 Polymed Taxol Product Models, Descriptions and Specifications
11.5.4 Polymed Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Polymed Taxol Sales by Product in 2024
11.5.6 Polymed Taxol Sales by Application in 2024
11.5.7 Polymed Taxol Sales by Geographic Area in 2024
11.5.8 Polymed Taxol SWOT Analysis
11.5.9 Polymed Recent Developments
11.6 TAPI (Teva)
11.6.1 TAPI (Teva) Corporation Information
11.6.2 TAPI (Teva) Business Overview
11.6.3 TAPI (Teva) Taxol Product Models, Descriptions and Specifications
11.6.4 TAPI (Teva) Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 TAPI (Teva) Recent Developments
11.7 Fresenius-kabi
11.7.1 Fresenius-kabi Corporation Information
11.7.2 Fresenius-kabi Business Overview
11.7.3 Fresenius-kabi Taxol Product Models, Descriptions and Specifications
11.7.4 Fresenius-kabi Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Fresenius-kabi Recent Developments
11.8 Huiang biopharma
11.8.1 Huiang biopharma Corporation Information
11.8.2 Huiang biopharma Business Overview
11.8.3 Huiang biopharma Taxol Product Models, Descriptions and Specifications
11.8.4 Huiang biopharma Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Huiang biopharma Recent Developments
11.9 Southpharma
11.9.1 Southpharma Corporation Information
11.9.2 Southpharma Business Overview
11.9.3 Southpharma Taxol Product Models, Descriptions and Specifications
11.9.4 Southpharma Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Southpharma Recent Developments
11.10 Yunnan Hande
11.10.1 Yunnan Hande Corporation Information
11.10.2 Yunnan Hande Business Overview
11.10.3 Yunnan Hande Taxol Product Models, Descriptions and Specifications
11.10.4 Yunnan Hande Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Yunnan Hande Recent Developments
11.11 Hainan Yew Pharm
11.11.1 Hainan Yew Pharm Corporation Information
11.11.2 Hainan Yew Pharm Business Overview
11.11.3 Hainan Yew Pharm Taxol Product Models, Descriptions and Specifications
11.11.4 Hainan Yew Pharm Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Hainan Yew Pharm Recent Developments
11.12 Jiangsu Yew Biotechnology
11.12.1 Jiangsu Yew Biotechnology Corporation Information
11.12.2 Jiangsu Yew Biotechnology Business Overview
11.12.3 Jiangsu Yew Biotechnology Taxol Product Models, Descriptions and Specifications
11.12.4 Jiangsu Yew Biotechnology Taxol Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Jiangsu Yew Biotechnology Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Taxol Industry Chain
12.2 Taxol Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Taxol Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Taxol Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Taxol Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Taxol Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Phyton
ScinoPharm
Novasep
Samyang
Polymed
TAPI (Teva)
Fresenius Kabi
Huiang biopharma
Southpharma
Yunnan Hande
Hainan Yew Pharm
Jiangsu Yew Biotechnology
List of Tables
 Table 1. Global Taxol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Taxol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Taxol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Taxol Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Taxol Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Taxol Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Taxol Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Taxol Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Taxol Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Taxol Sales Share by Manufacturers (2020-2025)
 Table 12. Global Taxol Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Taxol Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Taxol by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Taxol as of 2024)
 Table 16. Global Taxol Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Taxol Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Taxol Manufacturing Base and Headquarters
 Table 19. Global Taxol Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Taxol Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Taxol Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Taxol Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Taxol Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Taxol ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Taxol Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Taxol Sales by Application (2026-2031) & (K Dose)
 Table 30. Taxol High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Taxol Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Taxol Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Taxol ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Taxol Growth Accelerators and Market Barriers
 Table 37. North America Taxol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Taxol Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Taxol Growth Accelerators and Market Barriers
 Table 40. Europe Taxol Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Taxol Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Taxol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Taxol Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Taxol Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Taxol Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Taxol Investment Opportunities and Key Challenges
 Table 47. Central and South America Taxol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Taxol Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Taxol Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Phyton Corporation Information
 Table 51. Phyton Description and Major Businesses
 Table 52. Phyton Product Models, Descriptions and Specifications
 Table 53. Phyton Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. Phyton Sales Value Proportion by Product in 2024
 Table 55. Phyton Sales Value Proportion by Application in 2024
 Table 56. Phyton Sales Value Proportion by Geographic Area in 2024
 Table 57. Phyton Taxol SWOT Analysis
 Table 58. Phyton Recent Developments
 Table 59. ScinoPharm Corporation Information
 Table 60. ScinoPharm Description and Major Businesses
 Table 61. ScinoPharm Product Models, Descriptions and Specifications
 Table 62. ScinoPharm Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. ScinoPharm Sales Value Proportion by Product in 2024
 Table 64. ScinoPharm Sales Value Proportion by Application in 2024
 Table 65. ScinoPharm Sales Value Proportion by Geographic Area in 2024
 Table 66. ScinoPharm Taxol SWOT Analysis
 Table 67. ScinoPharm Recent Developments
 Table 68. Novasep Corporation Information
 Table 69. Novasep Description and Major Businesses
 Table 70. Novasep Product Models, Descriptions and Specifications
 Table 71. Novasep Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. Novasep Sales Value Proportion by Product in 2024
 Table 73. Novasep Sales Value Proportion by Application in 2024
 Table 74. Novasep Sales Value Proportion by Geographic Area in 2024
 Table 75. Novasep Taxol SWOT Analysis
 Table 76. Novasep Recent Developments
 Table 77. Samyang Corporation Information
 Table 78. Samyang Description and Major Businesses
 Table 79. Samyang Product Models, Descriptions and Specifications
 Table 80. Samyang Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. Samyang Sales Value Proportion by Product in 2024
 Table 82. Samyang Sales Value Proportion by Application in 2024
 Table 83. Samyang Sales Value Proportion by Geographic Area in 2024
 Table 84. Samyang Taxol SWOT Analysis
 Table 85. Samyang Recent Developments
 Table 86. Polymed Corporation Information
 Table 87. Polymed Description and Major Businesses
 Table 88. Polymed Product Models, Descriptions and Specifications
 Table 89. Polymed Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Polymed Sales Value Proportion by Product in 2024
 Table 91. Polymed Sales Value Proportion by Application in 2024
 Table 92. Polymed Sales Value Proportion by Geographic Area in 2024
 Table 93. Polymed Taxol SWOT Analysis
 Table 94. Polymed Recent Developments
 Table 95. TAPI (Teva) Corporation Information
 Table 96. TAPI (Teva) Description and Major Businesses
 Table 97. TAPI (Teva) Product Models, Descriptions and Specifications
 Table 98. TAPI (Teva) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. TAPI (Teva) Recent Developments
 Table 100. Fresenius-kabi Corporation Information
 Table 101. Fresenius-kabi Description and Major Businesses
 Table 102. Fresenius-kabi Product Models, Descriptions and Specifications
 Table 103. Fresenius-kabi Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. Fresenius-kabi Recent Developments
 Table 105. Huiang biopharma Corporation Information
 Table 106. Huiang biopharma Description and Major Businesses
 Table 107. Huiang biopharma Product Models, Descriptions and Specifications
 Table 108. Huiang biopharma Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. Huiang biopharma Recent Developments
 Table 110. Southpharma Corporation Information
 Table 111. Southpharma Description and Major Businesses
 Table 112. Southpharma Product Models, Descriptions and Specifications
 Table 113. Southpharma Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 114. Southpharma Recent Developments
 Table 115. Yunnan Hande Corporation Information
 Table 116. Yunnan Hande Description and Major Businesses
 Table 117. Yunnan Hande Product Models, Descriptions and Specifications
 Table 118. Yunnan Hande Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 119. Yunnan Hande Recent Developments
 Table 120. Hainan Yew Pharm Corporation Information
 Table 121. Hainan Yew Pharm Description and Major Businesses
 Table 122. Hainan Yew Pharm Product Models, Descriptions and Specifications
 Table 123. Hainan Yew Pharm Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 124. Hainan Yew Pharm Recent Developments
 Table 125. Jiangsu Yew Biotechnology Corporation Information
 Table 126. Jiangsu Yew Biotechnology Description and Major Businesses
 Table 127. Jiangsu Yew Biotechnology Product Models, Descriptions and Specifications
 Table 128. Jiangsu Yew Biotechnology Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 129. Jiangsu Yew Biotechnology Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Taxol Product Picture
 Figure 2. Global Taxol Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Natural Paclitaxel API Product Picture
 Figure 4. Semi-synthetic Paclitaxel API Product Picture
 Figure 5. Global Taxol Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Ovarian Cancer
 Figure 7. Cervical Cancer
 Figure 8. Breast Cancer
 Figure 9. Others
 Figure 10. Taxol Report Years Considered
 Figure 11. Global Taxol Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Taxol Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Taxol Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Taxol Revenue Market Share by Region (2020-2031)
 Figure 15. Global Taxol Sales (2020-2031) & (K Dose)
 Figure 16. Global Taxol Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 17. Global Taxol Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Taxol Sales Volume Market Share in 2024
 Figure 19. Global Taxol Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Natural Paclitaxel API Revenue Market Share by Manufacturer in 2024
 Figure 22. Semi-synthetic Paclitaxel API Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Taxol Sales Market Share by Type (2020-2031)
 Figure 24. Global Taxol Revenue Market Share by Type (2020-2031)
 Figure 25. Global Taxol Sales Market Share by Application (2020-2031)
 Figure 26. Global Taxol Revenue Market Share by Application (2020-2031)
 Figure 27. North America Taxol Sales YoY (2020-2031) & (K Dose)
 Figure 28. North America Taxol Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Taxol Sales Revenue (US$ Million) in 2024
 Figure 30. North America Taxol Sales Volume (K Dose) by Type (2020- 2031)
 Figure 31. North America Taxol Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Taxol Sales Volume (K Dose) by Application (2020-2031)
 Figure 33. North America Taxol Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Taxol Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Taxol Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Taxol Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Taxol Sales YoY (2020-2031) & (K Dose)
 Figure 38. Europe Taxol Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Taxol Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Taxol Sales Volume (K Dose) by Type (2020-2031)
 Figure 41. Europe Taxol Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Taxol Sales Volume (K Dose) by Application (2020-2031)
 Figure 43. Europe Taxol Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Taxol Revenue (2020-2031) & (US$ Million)
 Figure 45. France Taxol Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Taxol Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Taxol Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Taxol Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Taxol Sales YoY (2020-2031) & (K Dose)
 Figure 50. Asia-Pacific Taxol Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Taxol Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Taxol Sales Volume (K Dose) by Type (2020- 2031)
 Figure 53. Asia-Pacific Taxol Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Taxol Sales Volume (K Dose) by Application (2020-2031)
 Figure 55. Asia-Pacific Taxol Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Taxol Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Taxol Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Taxol Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Taxol Revenue (2020-2031) & (US$ Million)
 Figure 60. India Taxol Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Taxol Sales YoY (2020-2031) & (K Dose)
 Figure 62. Central and South America Taxol Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Taxol Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Taxol Sales Volume (K Dose) by Type (2021-2031)
 Figure 65. Central and South America Taxol Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Taxol Sales Volume (K Dose) by Application (2020-2031)
 Figure 67. Central and South America Taxol Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Taxol Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Taxol Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Taxol Sales YoY (2020-2031) & (K Dose)
 Figure 71. Middle East and Africa Taxol Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Taxol Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Taxol Sales Volume (K Dose) by Type (2021-2031)
 Figure 74. South America Taxol Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Taxol Sales Volume (K Dose) by Application (2020-2031)
 Figure 76. Middle East and Africa Taxol Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Taxol Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Taxol Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Taxol Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Taxol Revenue (2020-2025) & (US$ Million)
 Figure 81. Taxol Industry Chain Mapping
 Figure 82. Regional Taxol Manufacturing Base Distribution (%)
 Figure 83. Global Taxol Production Market Share by Region (2020-2031)
 Figure 84. Taxol Production Process
 Figure 85. Regional Taxol Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Paclitaxel Market Insights Forecast to 2030
Global Natural Paclitaxel Market Research Report 2024
Paclitaxel Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paclitaxel and Docetaxel APIs Market Research Report 2024
Paclitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Taxane Antineoplastic Drug Market Research Report 2024
Global Protein Bound Paclitaxel Market Research Report 2024
Cabazitaxel API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Protein bound Paclitaxel Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paclitaxel Micelles Market Research Report 2024
Global Paclitaxel and Its Analogue in Anticarcinoma Drugs Market Research Report 2024
Global Breast Cancer Treatment Drugs Market Insights Forecast to 2030
Liposomal Paclitaxel Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prostate Cancer Chemotherapy Drugs Market Research Report 2025
Global Paclitaxel Injection Market Insights Forecast to 2030
Global Paclitaxel eluting Stent Market Insights Forecast to 2030
Global Ovarian Cancer Microtubule Inhibitors Market Research Report 2025
Global Paclitaxel and Docetaxel Market Research Report 2024
Global Paclitaxel Coated Balloon Catheter Market Research Report 2024
Global Irinotecan Market Research Report 2024

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions